Insider · CIK 0001862082
Colleen Tupper
Files at COLL (COLLEGIUM PHARMACEUTICAL, INC). First filing Mar 10, 2025, latest Nov 7, 2025.
In brief
Colleen Tupper files SEC Form 4 as CFO at COLL (COLLEGIUM PHARMACEUTICAL, INC). Since Mar 10, 2025, Colleen Tupper has reported 0 open-market buys worth $0 and 5 open-market sells worth $1.9M, the latest filed on Nov 7, 2025.
A track record needs three past buys with six months of prices behind them; Colleen Tupper has 0, so none is measured yet.
The newest scored trade: sold $1.2M of COLL on Nov 6, 2025, filed Nov 7, 2025, scored 40 (moderate), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $1.2M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
COLL: COLLEGIUM PHARMACEUTICAL, INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | COLLEGIUM PHARMACEUTICAL, INC | $1.2M 30,000 shares | -19% | +65% from low0% from high | |
| 23Weak | COLLEGIUM PHARMACEUTICAL, INC | $228k 7,602 shares | -5% | - | |
| 22Weak | COLLEGIUM PHARMACEUTICAL, INC | $29k 977 shares | -1% | - | |
| 31Weak | COLLEGIUM PHARMACEUTICAL, INC | $313k 10,445 shares | -6% | - | |
| 27Weak | COLLEGIUM PHARMACEUTICAL, INC | $104k 3,453 shares | -2% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 6, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | 30,000 0.09% of outstanding | $1.2M | Nov 6, 2025 | none |
| Mar 21, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | 6,396 0.02% of outstanding | $192k | Mar 21, 2025 | $482k |
| Mar 20, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | 1,206 0.00% of outstanding | $36k | Mar 20, 2025 | $446k |
| Mar 14, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | 977 0.00% of outstanding | $29k | Mar 14, 2025 | $417k |
| Mar 11, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | 10,445 0.03% of outstanding | $313k | Mar 11, 2025 | $104k |
| Mar 7, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | 1,504 0.00% of outstanding | $45k | Mar 7, 2025 | $58k |
| Mar 6, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | 1,949 0.01% of outstanding | $58k | Mar 6, 2025 | none |
Transactions
Every row this insider has filed, 20 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +26,421 | $0.00 | $0 | 153,088 | Feb 12, 2026 |
| Feb 10, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +32,734 | $0.00 | $0 | 185,822 | Feb 12, 2026 |
| Feb 10, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | FTax withholding Common Stock | -11,861 | $46.75 | $555k | 173,961 | Feb 12, 2026 |
| Feb 10, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | FTax withholding Common Stock | -26,679 | $46.75 | $1.2M | 147,282 | Feb 12, 2026 |
| Nov 6, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | SOpen-market sale Common Stock10b5-1 | -25,142 | $40.38 | $1.0M | 131,525 | Nov 7, 2025 |
| Nov 6, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | SOpen-market sale Common Stock10b5-1 | -4,858 | $41.28 | $201k | 126,667 | Nov 7, 2025 |
| Mar 20, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | SOpen-market sale Common Stock10b5-1 | -1,206 | $30.00 | $36k | 163,063 | Mar 24, 2025 |
| Mar 21, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | SOpen-market sale Common Stock10b5-1 | -6,396 | $30.03 | $192k | 156,667 | Mar 24, 2025 |
| Mar 14, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | SOpen-market sale Common Stock10b5-1 | -977 | $30.00 | $29k | 164,269 | Mar 18, 2025 |
| Mar 11, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | SOpen-market sale Common Stock10b5-1 | -10,445 | $30.01 | $313k | 165,246 | Mar 13, 2025 |
| Mar 6, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | SOpen-market sale Common Stock10b5-1 | -1,949 | $30.00 | $58k | 177,195 | Mar 10, 2025 |
| Mar 7, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | SOpen-market sale Common Stock10b5-1 | -1,504 | $30.00 | $45k | 175,691 | Mar 10, 2025 |
| Feb 10, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +51,768 | $0.00 | $0 | 182,613 | Feb 12, 2025 |
| Feb 10, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +26,957 | $0.00 | $0 | 209,570 | Feb 12, 2025 |
| Feb 10, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | FTax withholding Common Stock | -8,109 | $30.52 | $247k | 201,461 | Feb 12, 2025 |
| Feb 10, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | FTax withholding Common Stock | -22,317 | $30.52 | $681k | 179,144 | Feb 12, 2025 |
| Feb 12, 2024 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +40,600 | $0.00 | $0 | 146,020 | Feb 14, 2024 |
| Feb 12, 2024 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +30,856 | $0.00 | $0 | 176,876 | Feb 14, 2024 |
| Feb 12, 2024 | COLL COLLEGIUM PHARMACEUTICAL, INC | FTax withholding Common Stock | -16,868 | $33.70 | $568k | 160,008 | Feb 14, 2024 |
| Feb 12, 2024 | COLL COLLEGIUM PHARMACEUTICAL, INC | FTax withholding Common Stock | -9,453 | $33.70 | $319k | 150,555 | Feb 14, 2024 |
Questions about Colleen Tupper
Answered from the filings on this page, as of the latest one.
Is Colleen Tupper buying or selling?
In the last 12 months Colleen Tupper reported 0 open-market buys worth $0 and 1 open-market sell worth $1.2M on SEC Form 4; the latest was sold $1.2M of COLL on Nov 6, 2025. Grants, option exercises and tax withholding are not counted.
How did Colleen Tupper's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Colleen Tupper has 0.
Where does Colleen Tupper file Form 4?
Colleen Tupper has filed Form 4 at COLL (COLLEGIUM PHARMACEUTICAL, INC) as EVP & Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.